124 related articles for article (PubMed ID: 10230870)
1. Morphometric evidence that YM175, a bisphosphonate, reduces trabecular bone resorption in ovariectomized dogs with dietary calcium restriction.
O'uchi N; Nishikawa H; Motoie H; Shikama H
Jpn J Pharmacol; 1999 Mar; 79(3):397-400. PubMed ID: 10230870
[TBL] [Abstract][Full Text] [Related]
2. Prevention of bone loss by bisphosphonate YM175 in ovariectomized dogs with dietary calcium restriction.
Motoie H; Kanoh H; Ogata S; Kawamuki K; Shikama H; Fujikura T
Jpn J Pharmacol; 1996 Jul; 71(3):239-46. PubMed ID: 8854206
[TBL] [Abstract][Full Text] [Related]
3. Effects of the bisphosphonate YM175 on bone mineral density, strength, structure, and turnover in ovariectomized beagles on concomitant dietary calcium restriction.
Motoie H; Nakamura T; O'uchi N; Nishikawa H; Kanoh H; Abe T; Kawashima H
J Bone Miner Res; 1995 Jun; 10(6):910-20. PubMed ID: 7572315
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of withdrawal of bisphosphonate incadronate disodium (YM175) on bone mineral density, mass, structure, and turnover in the lumbar vertebrae of ovariectomized rats.
Tamura Y; Miyakoshi N; Itoi E; Abe T; Kudo T; Tsuchida T; Kasukawa Y; Sato K
J Bone Miner Res; 2001 Mar; 16(3):541-9. PubMed ID: 11277272
[TBL] [Abstract][Full Text] [Related]
5. Maintaining bone mass by bisphosphonate incadronate disodium (YM175) sequential treatment after discontinuation of intermittent human parathyroid hormone (1-34) administration in ovariectomized rats.
Takano Y; Tanizawa T; Mashiba T; Endo N; Nishida S; Takahashi HE
J Bone Miner Res; 1996 Feb; 11(2):169-77. PubMed ID: 8822340
[TBL] [Abstract][Full Text] [Related]
6. Advantages of concurrent use of anabolic and antiresorptive agents over single use of these agents in increasing trabecular bone volume, connectivity, and biomechanical competence of rat vertebrae.
Kobayashi S; Shimizu T; Mehdi R; Nawata M; Kojima S; Tsutsumimoto T; Iorio R; Takaoka K
Bone; 1999 Dec; 25(6):703-12. PubMed ID: 10593416
[TBL] [Abstract][Full Text] [Related]
7. Responses of trabecular and cortical bone turnover and bone mass and strength to bisphosphonate YH529 in ovariohysterectomized beagles with calcium restriction.
Yoshida Y; Moriya A; Kitamura K; Inazu M; Okimoto N; Okazaki Y; Nakamura T
J Bone Miner Res; 1998 Jun; 13(6):1011-22. PubMed ID: 9626633
[TBL] [Abstract][Full Text] [Related]
8. Intramembranous and endochondral bone changes induced by a new bisphosphonate (YM175) in the beagle dog.
Nii A; Fujimoto R; Okazaki A; Narita K; Miki H
Toxicol Pathol; 1994; 22(5):536-44. PubMed ID: 7899783
[TBL] [Abstract][Full Text] [Related]
9. Inhibition by a new bisphosphonate (YM175) of bone resorption induced by the MBT-2 tumour of mice.
Nemoto R; Nishijima Y; Uchida K; Koiso K
Br J Cancer; 1993 May; 67(5):893-7. PubMed ID: 8494721
[TBL] [Abstract][Full Text] [Related]
10. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of YM175, a bisphosphonate, on the progression of experimental periodontitis in beagle dogs.
O'uchi N; Nishikawa H; Yoshino T; Kanoh H; Motoie H; Nishimori E; Shimaoka T; Abe T; Shikama H; Fujikura T; Matsue M; Matsue I
J Periodontal Res; 1998 May; 33(4):196-204. PubMed ID: 9689615
[TBL] [Abstract][Full Text] [Related]
12. Effect of ovariectomy on intraosseous vascularization and bone remodelling in rats: action of tiludronate.
Laroche M; Barbier A; Ludot I; Vernhet C; Thiechart M; Viguier G; Mazieres B
Osteoporos Int; 1996; 6(2):127-9. PubMed ID: 8704350
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of long-term sequential changes in bone mass and strength following withdrawal of incadronate disodium (YM175) in ovariectomized rats.
Miyakoshi N; Sato K; Tamura Y; Tsuchida T; Kudo T; Kasukawa Y
J Orthop Sci; 2001; 6(2):167-76. PubMed ID: 11484104
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of bisphosphonate (YM175) on bone resorption induced by a metastatic bone tumor.
Hiraga T; Tanaka S; Yamamoto M; Nakajima T; Ozawa H
Bone; 1996 Jan; 18(1):1-7. PubMed ID: 8717529
[TBL] [Abstract][Full Text] [Related]
15. Effects of YM175, a new-generation bisphosphonate, on hypercalcemia induced by tumor-derived bone resorbing factors in rats.
Takahashi K; Shirahata A; Fukushima S; Kokubo S; Teramura K; Usuda S
Jpn J Pharmacol; 1998 Feb; 76(2):155-63. PubMed ID: 9541278
[TBL] [Abstract][Full Text] [Related]
16. Sequential treatment with monofluorophosphate and zoledronic acid in osteoporotic rats.
Brance ML; Brun LR; Di Loreto VE; Lupo M; Rigalli A
Climacteric; 2014 Aug; 17(4):478-85. PubMed ID: 24205901
[TBL] [Abstract][Full Text] [Related]
17. Cellular mechanism of inhibition of osteoclastic resorption of bone and calcified cartilage by long-term pamidronate administration in ovariectomized mature rats.
Mayahara M; Sasaki T
Anat Rec A Discov Mol Cell Evol Biol; 2003 Sep; 274(1):817-26. PubMed ID: 12923892
[TBL] [Abstract][Full Text] [Related]
18. Long-term treatment of incadronate disodium accumulates microdamage but improves the trabecular bone microarchitecture in dog vertebra.
Komatsubara S; Mori S; Mashiba T; Ito M; Li J; Kaji Y; Akiyama T; Miyamoto K; Cao Y; Kawanishi J; Norimatsu H
J Bone Miner Res; 2003 Mar; 18(3):512-20. PubMed ID: 12619936
[TBL] [Abstract][Full Text] [Related]
19. Comparison of incadronate and alfacalcidol on increased bone turnover caused by ovariectomy in rats.
Teramura K; Fukushima S; Nozaki K; Kokubo S; Takahashi K
Eur J Pharmacol; 2002 Aug; 449(1-2):191-6. PubMed ID: 12163124
[TBL] [Abstract][Full Text] [Related]
20. Preexisting bone loss associated with ovariectomy in rats is reversed by parathyroid hormone.
Liu CC; Kalu DN; Salerno E; Echon R; Hollis BW; Ray M
J Bone Miner Res; 1991 Oct; 6(10):1071-80. PubMed ID: 1796755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
